Category: MS Drug Therapies

First-Ever Clinical Trial Exclusively in Black and Hispanic / Latinx People Living With Multiple Sclerosis Shows Genentech’s Ocrevus Effectively Manages Disease Activity

 October 10, 2023 Black and Hispanic / Latinx people with multiple sclerosis (MS) often experience more severe disease and greater…

Stuart Schlossman

How to give Ocrelizumab…Differently?! – presented by Aaron Boster, MD

  Stay informed with MS information, news and resources. Sign-up Here: https://bit.ly/3NkMIeR  Visit the MS Views and News articles and videos…

Stuart Schlossman

ECTRIMS: Sanofi to Present New Data for Tolebrutinib and Growing MS Pipeline

Media Update: Sanofi presents new data from robust MS clinical pipeline exploring multiple approaches to address important unmet patient needs…

Stuart Schlossman

Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD

 Late-breaking results from Phase III trial of Ocrevus (ocrelizumab) subcutaneous injection and Phase II trial of BTK inhibitor fenebrutinib in…

Stuart Schlossman

Generic and Biosimilar Medications for MS

 Generics and biosimilars are follow-on medications. A generic is a follow-on medication to a brand medication and a biosimilar is…

Stuart Schlossman

FDA Approves First Biosimilar to Treat Multiple Sclerosis

For Immediate Release: August 24, 2023 The U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab)…

Stuart Schlossman

LONG-acting glatiramer acetate (GA) being investigated as a once-monthly injection for the treatment of relapsing forms of multiple sclerosis (RMS)

 NEWS PROVIDED BY Viatris Inc.   07 Aug, 2023 Viatris and Mapi Pharma Announce FDA Acceptance of New Drug Application Filing for…

Stuart Schlossman

Should We Use Lemtrada for MS in 2023? A Neurologist’s Perspective

  Stay informed with MS information, news and resources. Sign-up Here: https://bit.ly/3NkMIeR  Visit the MS Views and News articles and videos…

Stuart Schlossman

Positive Phase III Results for Genentech’s Ocrevus (ocrelizumab)

 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Positive Results Announced from Phase 3 OCARINA II…

Stuart Schlossman

Review: Ocrevus best of 4 antibody therapies for progressive MS

 Drug found most effective also only one approved for PPMS by FDA by Steve Bryson, PhD | June 27, 2023 Among four antibody-based…

Stuart Schlossman

Categories

Latest Blog Posts